
|Articles|December 19, 2005
FDA to issue proposed rule for certain OTC shampoos
Advertisement
The FDA is issuing a proposed rule to amend the final monograph (FM) for OTC dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff. The agency is issuing this proposed rule after considering information submitted in a citizen petition. In 1993, FDA received a petition to amend the FM for OTC dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 9% coal tar solution and 1.5% menthol in a shampoo drug product to relieve scalp itching associated with dandruff. To submit electronic comments by March 9, 2006, visit
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
5




























